The trading price of Zevra Therapeutics Inc (NASDAQ:ZVRA) remained unchanged on Tuesday, August 06, closing at $7.88.
In examining the 52-week price action we see that the stock hit a 52-week high of $8.44 and a 52-week low of $3.89. Over the past month, the stock has gained 84.98% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zevra Therapeutics Inc, whose market valuation is $329.78 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.44 per share this quarter, however they have predicted annual earnings per share of -1.61 for current year and -0.61 for next year.
Analysts have forecast the company to bring in revenue of 4.36M for the current quarter, with the likely lows of 3.57M and highs of 5M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 27.72M.
On the technical side, indicators suggest ZVRA has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a Hold, while an average of long term indicators suggests that the stock is currently 50% Buy.
A quick review shows that ZVRA’s price is currently 28.51% off the SMA20 and 50.79% off the SMA50. The RSI metric on the 14-day chart is currently showing 72.03, and weekly volatility stands at 12.09%. When measured over the past 30 days, the indicator reaches 9.49%. Zevra Therapeutics Inc (NASDAQ:ZVRA)’s beta value is currently sitting at 1.78, while the Average True Range indicator is currently displaying 0.61.
To see how Zevra Therapeutics Inc stock has been performing in comparison to its peers in the industry, here are the numbers: ZVRA stock’s performance was 0.00% in the latest trading, and 62.81% in the past year.
An evaluation of the daily trading volume of Zevra Therapeutics Inc (NASDAQ:ZVRA) indicates that the 3-month average is 545.11K.
Currently, records show that 41.53 million of the company’s shares remain outstanding. The insiders hold 0.79% of outstanding shares, whereas institutions hold 33.35%. However, since the stock’s price has seen 20.31% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
